Arerugi = [Allergy]最新文献

筛选
英文 中文
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.404
{"title":"","authors":"","doi":"10.15036/arerugi.71.404","DOIUrl":"https://doi.org/10.15036/arerugi.71.404","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 5","pages":"404-405"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40600811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[FOOD-DEPENDENT EXERCISE-INDUCED ANAPHYLAXIS IMPROVED BY OMALIZUMAB PRESCRIBED FOR IDIOPATHIC CHRONIC URTICARIA]. [奥玛珠单抗治疗特发性慢性荨麻疹改善食物依赖性运动诱导的过敏反应]。
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.46
Sayaka Okazaki, Kei Doi, Natsuki Momo, Yuya Tanaka
{"title":"[FOOD-DEPENDENT EXERCISE-INDUCED ANAPHYLAXIS IMPROVED BY OMALIZUMAB PRESCRIBED FOR IDIOPATHIC CHRONIC URTICARIA].","authors":"Sayaka Okazaki,&nbsp;Kei Doi,&nbsp;Natsuki Momo,&nbsp;Yuya Tanaka","doi":"10.15036/arerugi.71.46","DOIUrl":"https://doi.org/10.15036/arerugi.71.46","url":null,"abstract":"<p><p>A 13-year-old male patient suffered several episodes of anaphylaxis during exercise after consuming wheat. Provocation tests (consisting of exercise after wheat ingestion) were conducted twice at our hospital. Both tests were positive, resulting in a diagnosis of food-dependent exercise-induced anaphylaxis (FDEIA) due to wheat. The patient was instructed to avoid exercise after wheat ingestion. The patient had also been previously diagnosed with idiopathic chronic urticaria, which was treated with antihistamines and leukotriene receptor antagonists. Since the idiopathic chronic urticaria worsened despite the use of these medications, 300 mg per four weeks of omalizumab was initiated. The patient's symptoms improved, and a third provocation test came back negative. The patient was asymptomatic without exercise restriction when treated with omalizumab. Omalizumab is not typically prescribed for treating food allergies and EIA in Japan; however, there are some reports on their effectiveness in treating them, suggesting omalizumab may also be helpful in resolving FDEIA symptoms.</p>","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 1","pages":"46-50"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39929052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.76
{"title":"","authors":"","doi":"10.15036/arerugi.71.76","DOIUrl":"https://doi.org/10.15036/arerugi.71.76","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 1","pages":"76"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39929060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A CHILD CASE OF DIFFUSE CUTANEOUS MASTOCYTOSIS]. [儿童弥漫性皮肤肥大细胞增多症1例]。
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.397
Yu Hoshino, Kaoruko Yoshida, Takafumi Numata, Tomonobu Ito, Chizu Egusa, Tatsuo Maeda, Noriyasu Sakai, Kazutoshi Harada, Yukari Okubo
{"title":"[A CHILD CASE OF DIFFUSE CUTANEOUS MASTOCYTOSIS].","authors":"Yu Hoshino,&nbsp;Kaoruko Yoshida,&nbsp;Takafumi Numata,&nbsp;Tomonobu Ito,&nbsp;Chizu Egusa,&nbsp;Tatsuo Maeda,&nbsp;Noriyasu Sakai,&nbsp;Kazutoshi Harada,&nbsp;Yukari Okubo","doi":"10.15036/arerugi.71.397","DOIUrl":"https://doi.org/10.15036/arerugi.71.397","url":null,"abstract":"<p><p>Cutaneous mastocytosis (CM) usually appears in childhood and improves substantially before adolescence. The c-KIT mutation of D816V is present in 36% and 20% of patients with childhood-onset CM and diffuse cutaneous mastocytosis (DCM), respectively. In some cases of childhood-onset DCM, the disease can progress to systemic mastocytosis; in others, it resolves spontaneously. Thus, assessing the prognosis is difficult. Herein, we described a case of DCM in an 11-month-old, male patient without a c-KIT mutation. The patient presented with dark brown macules and sporadic erythema topped by bullous lesions. A skin biopsy of the macule on the abdomen revealed accumulation of mast cells which were round to oval-shaped with amphophilic cytoplasm within the upper dermis. The patient had received H1 inhibitor until age 3 years and continued to experience blisters on the trunk. However, no severe symptoms, such as anaphylaxis, occurred. Included in this manuscript is a review of previous reports of childhood-onset DCM in Japan and cases specifically seen at our dermatology clinic.</p>","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 5","pages":"397-401"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40600809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PATIENT-ORIENTED ALLERGY SCIENCE, PATIENT-CENTERED ALLERGY PRACTICE]. 【以患者为中心的过敏科学,以患者为中心的过敏实践】。
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.1099
Makoto Nagata
{"title":"[PATIENT-ORIENTED ALLERGY SCIENCE, PATIENT-CENTERED ALLERGY PRACTICE].","authors":"Makoto Nagata","doi":"10.15036/arerugi.71.1099","DOIUrl":"https://doi.org/10.15036/arerugi.71.1099","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 9","pages":"1099-1104"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40684379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PHARMACOTHERAPY FOR VERNAL KERATOCONJUNCTIVITIS]. 春季角膜结膜炎的药物治疗。
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.359
Ken Fukuda
{"title":"[PHARMACOTHERAPY FOR VERNAL KERATOCONJUNCTIVITIS].","authors":"Ken Fukuda","doi":"10.15036/arerugi.71.359","DOIUrl":"https://doi.org/10.15036/arerugi.71.359","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 5","pages":"359-364"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40519059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[OCULAR SURFACE INFECTION COMPLICATED BY ALLERGIC CONJUNCTIVAL DISEASES]. [眼表感染并发过敏性结膜疾病]。
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.365
Jun Shoji
{"title":"[OCULAR SURFACE INFECTION COMPLICATED BY ALLERGIC CONJUNCTIVAL DISEASES].","authors":"Jun Shoji","doi":"10.15036/arerugi.71.365","DOIUrl":"https://doi.org/10.15036/arerugi.71.365","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 5","pages":"365-372"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40519060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[SKIN CARE OF BLEPHARITIS IN PATIENTS WITH ATOPIC DERMATITIS]. 【特应性皮炎患者睑炎的皮肤护理】。
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.920
Risa Tamagawa-Mineoka
{"title":"[SKIN CARE OF BLEPHARITIS IN PATIENTS WITH ATOPIC DERMATITIS].","authors":"Risa Tamagawa-Mineoka","doi":"10.15036/arerugi.71.920","DOIUrl":"https://doi.org/10.15036/arerugi.71.920","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 8","pages":"920-924"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33458586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[THE DEVELOPMENT OF CANCER IMMUNOTHERAPY: REGULATORY MECHANISM OF T CELL RESPONSE]. 癌症免疫治疗的发展:t细胞反应的调节机制。
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.931
Yoshiko Iwai
{"title":"[THE DEVELOPMENT OF CANCER IMMUNOTHERAPY: REGULATORY MECHANISM OF T CELL RESPONSE].","authors":"Yoshiko Iwai","doi":"10.15036/arerugi.71.931","DOIUrl":"https://doi.org/10.15036/arerugi.71.931","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 8","pages":"931-933"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33458588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arerugi = [Allergy] Pub Date : 2022-01-01 DOI: 10.15036/arerugi.71.617
{"title":"","authors":"","doi":"10.15036/arerugi.71.617","DOIUrl":"https://doi.org/10.15036/arerugi.71.617","url":null,"abstract":"","PeriodicalId":290443,"journal":{"name":"Arerugi = [Allergy]","volume":"71 6-7","pages":"617-627"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33458944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书